2018
DOI: 10.18632/oncotarget.25175
|View full text |Cite
|
Sign up to set email alerts
|

Natural products: a hope for glioblastoma patients

Abstract: Glioblastoma (GBM) is one of the most aggressive malignant tumors with an overall dismal survival averaging one year despite multimodality therapeutic interventions including surgery, radiotherapy and concomitant and adjuvant chemotherapy. Few drugs are FDA approved for GBM, and the addition of temozolomide (TMZ) to standard therapy increases the median survival by only 2.5 months. Targeted therapy appeared promising in in vitro monolayer cultures, but disappointed in preclinical and clinical trials, partly du… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
50
0
3

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 81 publications
(54 citation statements)
references
References 274 publications
(307 reference statements)
0
50
0
3
Order By: Relevance
“…Interestingly, various authors illustrated how many natural agents exhibited antitumor action by affecting the role of HDAC proteins and other regulators of gene expression. Over recent years, a series of work introduced the effects of different natural compounds on GBM [22,23]. Among these natural agents, a saffron extract (SE) compound named crocetin (CCT) raised significant interest due to its capacity to impair the survival and progression of different cancer types [24,25].…”
Section: Introductionmentioning
confidence: 99%
“…Interestingly, various authors illustrated how many natural agents exhibited antitumor action by affecting the role of HDAC proteins and other regulators of gene expression. Over recent years, a series of work introduced the effects of different natural compounds on GBM [22,23]. Among these natural agents, a saffron extract (SE) compound named crocetin (CCT) raised significant interest due to its capacity to impair the survival and progression of different cancer types [24,25].…”
Section: Introductionmentioning
confidence: 99%
“…Trogrlić et al demonstrated herbal medicines induced tumor regression and prolonged survival in glioblastoma patients 6 . In addition, in cells and animal models indicated several herbal compounds inhibited progression of glioblastoma through induction of apoptosis, arrest of cell cycle progression, promotion of anticancer immunity, and disruption of oncogenic signaling transduction 7,8 . Many herbal compounds were indicated to modulate antidepressant effect and attenuate hypoxic stress or toxicity agents‐induced brain damage in animal models 9,10 .…”
Section: Introductionmentioning
confidence: 99%
“…There may be only one compound eligible for clinical approval among those natural compounds reported in the literature. Many natural compounds have a direct chemopreventive effect on glioma, but there are some compounds that can help to overcome the significant limitations of glioma therapy by sensitizing glioma cells to chemotherapeutic agents or permeabilizing BBB for chemotherapeutic agents (Vengoji, Macha, Batra, & Shonka, ).…”
Section: Natural Product and Glioma Therapymentioning
confidence: 99%
“…CSCs are mainly responsible for tumor recurrence in glioma. Eckol, a phlorotannin, exhibits anti‐CSCs property in U87 and U373 cells (Vengoji et al, ).…”
Section: Natural Product and Glioma Therapymentioning
confidence: 99%
See 1 more Smart Citation